Daniel W. Muehl

Overview

Daniel W. Muehl received an average of $2M in total compensation, including $417K in salary, at Clovis Oncology from 2016 to 2021. Daniel Muehl also received an average of $239K at Repligen between 2007 and 2008.

Related executives

We found 18 more executives who work or worked at Clovis Oncology and Repligen.

Tony Hunt

Repligen

Chief Executive Officer

Patrick Mahaffy

Clovis Oncology

Chief Executive Officer

Jon Snodgres

Repligen

Chief Financial Officer

James Bylund

Repligen

Chief Operating Officer

Ralf Kuriyel

Repligen

Senior Vice President of Research and Development

Christine Gebski

Repligen

Senior Vice President of Filtration &Chromatography

Lindsey Rolfe

Clovis Oncology

Chief Medical Officer

Gillian Ivers-Read

Clovis Oncology

EVP and Chief Regulatory Officer

News

You may also like